Quotes with Resistance & Support
Market Information

Ess Dee Q2 PAT up 55% YoY

This article was posted on Nov 3, 2008 and is filed under Stock News

Ess Dee Q2 revenues increase by 64% to Rs1.25bn from Rs763.4mn Ess Dee Aluminium Ltd, one of India’s largest providers of pharma packaging solutions, has announced its results for the quarter and half year ended 30th September 2008. Q2 FY09 results compared with Q2 FY08 results:..

Revenues increase by 64.04% to Rs1.25bn from Rs763.4mn

Operating profits stand at Rs323.5mn Vs Rs185.9mn, indicating 74% growth

PAT rises 55.58% to Rs229.2mn from Rs147.3mn

EPS improves to Rs8.24 from Rs5.53

H1 FY09 results compared with H1 FY08 results:

Revenues up 54.45% to Rs2.32bn from Rs1.5bn

EBIDTA improves 56.3% to Rs661.2mn from Rs423mn

Net profits increase by 42.9% to Rs443.3mn from Rs310.2mn

EPS at Rs15.93 from Rs11.69

Commenting on the performance in Q2 FY09 Sudip Dutta, Chairman & Managing Director, said,

“We are thankful to our investors for their support & we feel proud to announce our financial result which has seen healthy growth in the second quarter of FY09. The company is plotting robust order books with increasing demand due to consolidation of market as customers are shifting their buying from unorganised sectors to preferred organised sector company like EDAL”.

Key Strengths:

EDAL plants located at Daman and Goa, are modeled on the latest generation CGMP practices and are the best in the packaging laminate space. The company has skilled and trained manpower, who are the cream in the Indian packaging industry.

Key Developments:

The company is getting ready for higher demands in laminates and therefore has decided to import latest hi-tech ultra modern multi- colour printing machine to be installed by 4th quarter. The anti-counterfeit products are getting wide spread acceptance from the Pharma giants in India to protect their big brands from fakes & counterfeit products. The company has received DMF Type III approval from USFDA for its newly introduced products like cold formed blister foil, child resistant foil and tropicalised laminates, giving marketing leveraging capabilities to Pharma giants to source these products from EDAL for their exports to regulated markets.

source: Indiainfoline

Tags: , , , ,

Similar Posts:

Breakouts

+ve 30 DMA    50 DMA    150 DMA    200 DMA
-ve 30 DMA    50 DMA    150 DMA    200 DMA

Latest Query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam
Status: Awaiting reply

Market Stats

Search Our Archives

Latest Investment Idea

Recent Comments